Cartesian Therapeutics, Inc. — Director's Dealing 2024

Jan 4, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cartesian Therapeutics, Inc. (RNAC)
CIK: 0001453687
Period of Report: 2024-01-02

Reporting Person: Kalayoglu Murat (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-02	Common Stock	A	178000	—	Acquired	435739	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-02	Stock Option (Right to Buy)	$0.6552	A	228000	Acquired	2034-01-01	Common Stock (228000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3303699	Indirect

Footnotes

F1: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027.

F2: Shares are held in a trust (the "Trust") for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the trust.

F3: This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027.